FSCN1 was also shown to be transcriptionally regulated by β-catenin, a key effector of the Wnt/Wingless signalling pathway encoded by the CTNNB1 gene, which is a frequently altered oncogenic driver in ACC [27] (Figure 1 and Figure 3). The gene discussed is FSCN1; the disease is adrenal cortex carcinoma.